Utilize este identificador para referenciar este registo: http://hdl.handle.net/10362/180262
Título: Evaluation of Biotechnological Active Peptides Secreted by Saccharomyces cerevisiae with Potential Skin Benefits
Autor: Maurício, Elisabete Muchagato
Branco, Patrícia
Araújo, Ana Luiza Barros
Roma-Rodrigues, Catarina
Lima, Katelene
Duarte, Maria Paula
Fernandes, Alexandra R.
Albergaria, Helena
Palavras-chave: anti-ageing
anti-collagenase
anti-inflammatory
antimicrobial peptides
biopreservatives
biotechnological active peptides
Saccharomyces cerevisiae
Microbiology
Biochemistry
Pharmacology, Toxicology and Pharmaceutics(all)
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)
SDG 3 - Good Health and Well-being
SDG 7 - Affordable and Clean Energy
SDG 9 - Industry, Innovation, and Infrastructure
SDG 12 - Responsible Consumption and Production
Data: Set-2024
Resumo: Biotechnological active peptides are gaining interest in the cosmetics industry due to their antimicrobial, anti-inflammatory, antioxidant, and anti-collagenase (ACE) effects, as well as wound healing properties, making them suitable for cosmetic formulations. The antimicrobial activity of peptides (2–10 kDa) secreted by Saccharomyces cerevisiae Ethanol-Red was evaluated against dermal pathogens using broth microdilution and challenge tests. ACE was assessed using a collagenase activity colorimetric assay, antioxidant activity via spectrophotometric monitoring of nitrotetrazolium blue chloride (NBT) reduction, and anti-inflammatory effects by quantifying TNF-α mRNA in lipopolysaccharides (LPS)-exposed dermal fibroblasts. Wound healing assays involved human fibroblasts, endothelial cells, and dermal keratinocytes. The peptides (2–10 kDa) exhibited antimicrobial activity against 10 dermal pathogens, with the Minimum Inhibitory Concentrations (MICs) ranging from 125 µg/mL for Staphylococcus aureus to 1000 µg/mL for Candida albicans and Streptococcus pyogenes. In the challenge test, peptides at their MICs reduced microbial counts significantly, fulfilling ISO 11930:2019 standards, except against Aspergillus brasiliensis. The peptides combined with MicrocareⓇ SB showed synergy, particularly against C. albicans and A. brasilensis. In vitro, the peptides inhibited collagenase activity by 41.8% and 94.5% at 250 and 1000 µg/mL, respectively, and demonstrated antioxidant capacity. Pre-incubation with peptides decreased TNF-α expression in fibroblasts, indicating anti-inflammatory effects. The peptides do not show to promote or inhibit the angiogenesis of endothelial cells, but are able to attenuate fibrosis, scar formation, and chronic inflammation during the final phases of the wound healing process. The peptides showed antimicrobial, antioxidant, ACE, and anti-inflammatory properties, highlighting their potential as multifunctional bioactive ingredients in skincare, warranting further optimization and exploration in cosmetic applications.
Descrição: © 2024 by the authors. Licensee MDPI, Basel, Switzerland.
Peer review: yes
URI: http://hdl.handle.net/10362/180262
DOI: https://doi.org/10.3390/antibiotics13090881
ISSN: 2079-6382
Aparece nas colecções:Home collection (FCT)

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
antibiotics-13-00881.pdf2,97 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.